The American Health Care Association and National Center for Assisted Living (AHCA/NCAL) has released a state by state breakdown of the estimated cost to COVID-19 test every nursing home resident and staff just once, which would cost $440 million nationwide. As this shows, the cost of ongoing COVID-19 testing of nursing home residents and staff is unsustainable without additional funding and support from federal and state governments. Even the CDC’s recent recommendation to test all nursing
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Philips Launches HealthSuite Clinical Trial Accelerator
What You Should Know:
Philips launches HealthSuite Clinical Trial Accelerator
to help life science organizations run more flexible, patient-centric clinical
trials.
Clinical Trial Accelerator enables patient-centric trials
at home, managing the collection of data while providing the security and
compliance expected from both patients and life science organizations.
Philips, today
announced Clinical
Trial Accelerator on Philips HealthSuite. This new tailored set of
capabilities
Read More
COVID-19 Testing Provider Curative Acquires KorvaLabs
What You Should Know:
COVID-19 testing provider Curative Acquires KorvaLabs, a
CLIA certified and DEA licensed analytical laboratory.
Easy to use, accurate, and rapidly scalable oral fluid test will continue to be produced and processed in KorvaLabs’ San Dimas, CA facilities.
COVID-19 testing startup Curative
Inc. announced today that it has completed the acquisition
of KorvaLabs, Inc., a CLIA certified and DEA licensed analytical
laboratory based in San Dimas,
Read More
FDA Approves Everlywell’s COVID-19 Test Home Collection Kit Using Nasal Swabs
What You Should Know:
- FDA approves Everlywell’s COVID-19 Test Home Collection Kit under the emergency use authorization (EUA) allows an individual to self-collect a nasal sample at home using Everlywell’s authorized kit.
- The Everlywell home-collection kit is currently the only authorized COVID-19 at-home sample collection kit for use with multiple authorized COVID-19 diagnostic tests.
The U.S. Food and Drug
Administration (FDA) has issued emergency use authorization (EUA) to
Read More
FDA Alerts Public on Accuracy Issues with Abbott’s Rapid COVID-19 Tests
What You Should Know:
- FDA issues alert about accuracy concerns with Abbott’s ID Now COVID-19 rapid point-of-care tests that could return false negative results.
- The FDA reports it is sharing early information available about potential inaccurate results in the spirit of transparency and is working with Abbott to analyze the information gathered to date.
On late Thursday, the U.S. Food and Drug Administration (FDA) issued an alert to the public about potential inaccurate
Read More
UCSF and AWS Collaborate on 2 COVID-19 Genome Sequencing Projects
What You Should Know:
Amazon Web Services (AWS) and the University of
California, San Francisco (UCSF) collaborate on two projects
involving sequencing the genomes of the viruses infecting hundreds of
COVID-19 patients in the Bay Area using CRISPR gene-technology in a clinical
research study.
Amazon Web Services (AWS)
announced this week it has offered their support and donated service credits
provided by the AWS Diagnostic
Development Initiative for
Read More
SubjectWell Launches Patient Registry of 10k+ Patients for COVID-19 Clinical Trials
What You Should Know:
- SubjectWell launches a patient registry list of 10,000 individuals in the US interested in participating in COVID-19 clinical trials and research.
- The new COVID-19 patient registry will accelerate the patient recruitment process for COVID-19 research, giving researchers access to interested individuals who could randomize for various types of trials, whether they are healthy volunteers with no previous exposure to COVID-19, currently sick with the virus, or who
Read More
Change Healthcare Launches COVID-19 Research Database Using De-Identified Data to Track Disease Progression
What You Should Know:
- Change Healthcare announced a new online COVID-19 research database to track disease progression, treatment efficacy, for qualified public and private healthcare organizations using de-identified data to understand disease progression and improve intervention.
- Actionable insight “beyond the diagnosis” enables health researchers to better understand COVID-19 progression, intervention effectiveness, and impacts on the healthcare system.
Today
Read More
BrightInsight, CSL Behring Form Global Digital Health Partnership
What You Should Know:
- CSL Behring selects the BrightInsight Platform to build and manage its digital health solutions within a regulatory-compliant environment.
- The digital health partnership extends across therapeutic areas, including immunology, hematology and respiratory, among others.
BrightInsight,
Inc., a provider of the regulated IoT platform for biopharma and medtech,
and CSL Behring, a leading
biotechnology company, announced a global digital health partnership
Read More
Janssen Pharmaceuticals Collaborates with Alveo on Rapid At-Home COVID-19 Test
What You Should Know:
- Johnson & Johnson’s Janssen Pharmaceuticals company announced it is working with Alveo Technologies, an innovative diagnostic testing company, to help bring its COVID-19 rapid at-home self-testing platform for viral infectious diseases to market.
- Johnson & Johnson’s Janssen Pharmaceuticals company will work with and fund Alveo to accelerate research and development of be.well .
- Alveo will
Read More
